FULC

NASDAQStock

Fulcrum Therapeutics, Inc.

$7.54-0.10 (-1.25%)

52-Week Range

$2.51
$14.60

Key Stats

Market Cap

407.7M

P/E Ratio

Dividend Yield

Beta

3.29

Volume

347.0K

Avg Volume

1.3M

Performance

1M

-28.22%

3M

-40.94%

6M

+4.52%

YTD

-30.13%

1Y

+144.55%

3Y

+107.34%

5Y

-37.15%

Price Chart

ETF Exposure

FULC is held by 64 ETFs

ETFFund NameWeight
DFACDimensional - US Core Equity 2 ETF0.00%
DFUSDimensional - US Equity Market ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 2 of 2

About FULC ETF Exposure

Fulcrum Therapeutics, Inc. (FULC) is held by 64 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 407.7M, FULC is a widely held institutional stock. The stock currently trades at $7.54. Investors can gain exposure to FULC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold FULC, sorted by portfolio weight.